MedPath
HSA Approval

ASTRODAL CAPSULES 100MG

SIN15066P

ASTRODAL CAPSULES 100MG

ASTRODAL CAPSULES 100MG

August 16, 2016

LOTUS INTERNATIONAL PTE. LTD.

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.
Licence HolderLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L01AX03

temozolomide

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Lotus Pharmaceutical Co., Ltd. Nantou Plant

Active Ingredients

Temozolomide

100mg

Temozolomide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.